Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation
Chapter 2. Executive Summary
2.1. Global VV Market Portraiture
2.2. Global VV Market, by Vaccine Type, 2017 (US$ Mn)
2.3. Global VV Market, by Animal Type, 2017 (US$ Mn)
2.4. Global VV Market, by Disease Type, 2017 (US$ Mn)
2.5. Global VV Market, by Geography, 2017 (US$ Mn)
Chapter 3. Global VV Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global VV Market, by Key Players, 2017
Chapter 4. Global VV Market, by Vaccine Type, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Live-attenuated
4.3. Inactivated
4.4. Toxoids
4.5. Recombinant subunit
4.6. RNA/DNA-based
4.7. Vectored-based
Chapter 5. Global VV Market, by Animal Type, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Livestock
5.2.1. Bovine
5.2.2. Poultry
5.2.3. Porcine
5.2.4. Others (Sheep/goats, Fish)
5.3. Pet Animals
5.3.1. Feline
5.3.2. Canine
5.3.3. Equine
5.3.4. Others (Rodents, Birds etc.)
Chapter 6. Global VV Market, by Disease Type, 2016-2026 (US$ Mn)
6.1. Overview
6.2. Viral Diseases
6.3. Bacterial Diseases
6.4. Parasitic Diseases
6.5. Non-infectious Diseases
6.6. Fertility
Chapter 7. Global VV Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.1.1. North America VV Market, 2016-2026 (US$ Mn)
7.1.2. North America VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
7.1.3. North America VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
7.1.4. North America VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
7.1.5. North America VV Market, by Country, 2016 – 2026 (US$ Mn)
7.1.5.1. U.S.
7.1.5.2. Canada
7.2. Europe VV Market, 2016 – 2026 (US$ Mn)
7.2.1. Europe VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
7.2.2. Europe VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
7.2.3. Europe VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
7.2.4. Europe VV Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.2.4.1. U.K.
7.2.4.2. Germany
7.2.4.3. Rest of Europe
7.3. Asia Pacific VV Market, 2016 – 2026 (US$ Mn)
7.3.1. Asia Pacific VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
7.3.2. Asia Pacific VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
7.3.3. Asia Pacific VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
7.3.4. Asia Pacific VV Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.3.4.1. China
7.3.4.2. Japan
7.3.4.3. Rest of Asia Pacific
7.4. Latin America VV Market, 2016 – 2026 (US$ Mn)
7.4.1. Latin America VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
7.4.2. Latin America VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
7.4.3. Latin America VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
7.4.4. Latin America VV Market, by Country/Region, 2016 – 2026 (US$ Mn)
7.4.4.1. Brazil
7.4.4.2. Mexico
7.4.4.3. Rest of Latin America
7.5. Middle East & Africa VV Market, 2016 – 2026 (US$ Mn)
7.5.1. Middle East & Africa VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
7.5.2. Middle East & Africa VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
7.5.3. Middle East & Africa VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
7.5.4. Middle East & Africa VV Market, by Region, 2016 – 2026 (US$ Mn)
7.5.4.1. GCC
7.5.4.2. Rest of Middle East & Africa
Chapter 8. Company Profiles
8.1. Merck Animal Health
8.1.1. Business Description
8.1.2. Financial Information (Subject to Data Availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Zoetis, Inc.
8.3. Merial (Boehringer Ingelheim International GmbH)
8.4. Elanco Animal Health
8.5. Bayer Animal Health
8.6. Novartis Animal Health
8.7. Virbac Group
8.8. Ceva Santé Animale S.A.
8.9. Biovac
List of Figures
FIG 1. VV Market: Research Methodology
FIG 2. Deep Brain Stimulation Devices: Market Segmentation
FIG 3. Global VV Market, by Vaccine Type, 2017 (US$ Mn)
FIG 4. Global VV Market, by Animal Type, 2017 (US$ Mn)
FIG 5. Global VV Market, by Disease Type, 2017 (US$ Mn)
FIG 6. Global VV Market, by Geography, 2017 (US$ Mn)
FIG 7. Attractive Investment Proposition, by Geography, 2017
FIG 8. Competitive Analysis: Global VV Market, by Key Players, 2017
FIG 9. Global Live-attenuated VV Market, 2016-2026(US$ Mn)
FIG 10. Global Inactivated VV Market, 2016-2026 (US$ Mn)
FIG 11. Global Toxoids VV Market, 2016-2026 (US$ Mn)
FIG 12. Global Low-tech VV Market, 2016-2026 (US$ Mn)
FIG 13. Global Recombinant subunit VV Market, 2016-2026 (US$ Mn)
FIG 14. Global RNA/DNA-based VV Market, 2016-2026 (US$ Mn)
FIG 15. Global Vectored-based VV Market, 2016-2026 (US$ Mn)
FIG 16. Global Bovine VV Market, 2016-2026 (US$ Mn)
FIG 17. Global Poultry VV Market, 2016-2026 (US$ Mn)
FIG 18. Global Porcine VV Market, 2016-2026 (US$ Mn)
FIG 19. Global VV Market for Other Livestock, 2016-2026 (US$ Mn)
FIG 20. Global Feline VV Market, 2016-2026 (US$ Mn)
FIG 21. Global Canine VV Market, 2016-2026 (US$ Mn)
FIG 22. Global Equine VV Market, 2016-2026 (US$ Mn)
FIG 23. Global VV Market for Other Pet Animals, 2016-2026 (US$ Mn)
FIG 24. Global VV Market for Viral Diseases, 2016-2026 (US$ Mn)
FIG 25. Global VV Market for Bacterial Diseases, 2016-2026 (US$ Mn)
FIG 26. Global VV Market for Parasitic Diseases, 2016-2026 (US$ Mn)
FIG 27. Global Veterinary Vaccines (VV) Market for Non-infectious Diseases, 2016-2026 (US$ Mn)
FIG 28. Global VV Market for Fertility, 2016-2026 (US$ Mn)
FIG 29. U.S. VV Market, 2016-2026 (US$ Mn)
FIG 30. Canada VV Market, 2016-2026 (US$ Mn)
FIG 31. U.K. VV Market, 2016-2026 (US$ Mn)
FIG 32. Germany VV Market, 2016-2026 (US$ Mn)
FIG 33. Rest of Europe VV Market, 2016-2026 (US$ Mn)
FIG 34. China VV Market, 2016-2026 (US$ Mn)
FIG 35. Japan VV Market, 2016-2026 (US$ Mn)
FIG 36. Rest of Asia Pacific VV Market, 2016-2026 (US$ Mn)
FIG 37. Brazil VV Market, 2016-2026 (US$ Mn)
FIG 38. Mexico VV Market, 2016-2026 (US$ Mn)
FIG 39. Rest of Latin America VV Market, 2016-2026 (US$ Mn)
FIG 40. GCC VV Market, 2016-2026 (US$ Mn)
FIG 41. Rest of Middle East and Africa VV Market, 2016-2026 (US$ Mn)
List of Tables
TABLE 1 Global Veterinary Vaccines (VV) Market Portraiture
TABLE 2 Global VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 3 Global VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global VV Market for Livestock Animals, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global VV Market for Pet Animals, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 Global VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 7 Global VV Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 8 North America VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 9 North America VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 10 North America VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 11 North America VV Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 12 Europe VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 13 Europe VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 14 Europe VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 15 Europe VV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 16 Asia Pacific VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 17 Asia Pacific VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 18 Asia Pacific VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 19 Asia Pacific VV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Latin America VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 21 Latin America VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 22 Latin America VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 23 Latin America VV Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 24 Middle East and Africa VV Market, by Vaccine Type, 2016 – 2026 (US$ Mn)
TABLE 25 Middle East and Africa VV Market, by Animal Type, 2016 – 2026 (US$ Mn)
TABLE 26 Middle East and Africa VV Market, by Disease Type, 2016 – 2026 (US$ Mn)
TABLE 27 Middle East and Africa VV Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 28 Merck Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 Zoetis, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 30 Merial (Boehringer Ingelheim International GmbH): Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 31 Elanco Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 32 Bayer Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 33 Novartis Animal Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 34 Virbac Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 35 Ceva Santé Animale S.A.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 Biovac: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)